Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last $7.41 USD
Change Today -0.14 / -1.85%
Volume 707.7K
ANTH On Other Exchanges
As of 8:10 PM 08/28/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Paul F. Truex MBA

Chief Executive Officer, President and Director,Anthera Pharmaceuticals, Inc.
AgeTotal Calculated CompensationThis person is connected to 56 board members in 6 different organizations across 9 different industries.

See Board Relationships
As of Fiscal Year 2014


Mr. Paul F. Truex, MBA, founded Anthera Pharmaceuticals, Inc. in 2004 and has been its Chief Executive Officer and President since September 2004. Mr. Truex was responsible for negotiating Anthera's multiple product licenses from Eli Lilly and Amgen. He served as the President of Peninsula Pharmaceuticals Inc. from October 2001 to September 14, 2004 and also as its Chief Executive Officer from June 2002 to September 14, 2004. He was the Founder of Peninsula Pharmaceuticals. ...

Read Full Background

Corporate Headquarters*

25801 Industrial Boulevard
Hayward, California 94545

United States

Phone: 510-856-5600
Fax: 510-856-5597

Board Members Memberships*

Independent Director
Chief Executive Officer, President and Director
Independent Director and Member of Compensation Committee


University of Waterloo
Indiana University, Bloomington

Other Affiliations*

Annual Compensation*

Total Annual Compensation$515,000

Stock Options*

Restricted Stock Awards$12,750
Exercised Options2,000
Exercised Options Value$2,620
Exercisable Options230,995
Unexercisable Options836,250
Total Value of Options$2,620
Total Number of Options1,069,245

Total Compensation*

Total Annual Cash Compensation$916,718
Total Short Term Compensation$515,000
Other Long Term Compensation$12,750
Total Calculated Compensation$1,379,227
*Data is at least as current as the most recent Definitive Proxy.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
ANTH:US $7.41 USD -0.14


There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact ANTHERA PHARMACEUTICALS INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at